[HTML][HTML] Vanadium as potential therapeutic agent for COVID-19: A focus on its antiviral, antiinflamatory, and antihyperglycemic effects

S Semiz - Journal of Trace Elements in Medicine and Biology, 2022 - Elsevier
An increasing evidence suggests that vanadium compounds are novel potential drugs in the
treatment of diabetes, atherosclerosis, and cancer. Vanadium has also demonstrated …

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu… - Nature, 2023 - nature.com
Critical illness in COVID-19 is an extreme and clinically homogeneous disease phenotype
that we have previously shown to be highly efficient for discovery of genetic associations …

A prenylated dsRNA sensor protects against severe COVID-19

A Wickenhagen, E Sugrue, S Lytras, S Kuchi… - Science, 2021 - science.org
INTRODUCTION Interferons (IFNs) are cytokines that are rapidly deployed in response to
invading pathogens. By initiating a signaling cascade that stimulates the expression of …

[HTML][HTML] Genome-wide association studies of COVID-19: Connecting the dots

LC Ferreira, CEM Gomes, JF Rodrigues-Neto… - Infection, Genetics and …, 2022 - Elsevier
Genome-wide association studies (GWASs) are a research approach used to identify
genetic variants associated with common diseases, like COVID-19. The lead genetic …

Whole-genome sequencing reveals host factors underlying critical COVID-19

A Kousathanas, E Pairo-Castineira, K Rawlik… - Nature, 2022 - nature.com
Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic
variation influences the development of illness requiring critical care or hospitalization,–after …

Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone

PJ Siska, SM Decking, N Babl, C Matos… - The Journal of …, 2021 - Am Soc Clin Investig
Metabolic pathways regulate immune responses and disrupted metabolism leads to immune
dysfunction and disease. Coronavirus disease 2019 (COVID-19) is driven by imbalanced …

Tissue proteomic analysis identifies mechanisms and stages of immunopathology in fatal COVID-19

CD Russell, A Valanciute, NN Gachanja… - American journal of …, 2022 - atsjournals.org
Immunopathology occurs in the lung and spleen in fatal coronavirus disease (COVID-19),
involving monocytes/macrophages and plasma cells. Antiinflammatory therapy reduces …

SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis

J Zhu, G Wang, X Huang, H Lee, JG Lee… - Communications …, 2022 - nature.com
SARS-CoV-2 infection causes COVID-19, a severe acute respiratory disease associated
with cardiovascular complications including long-term outcomes. The presence of virus in …

Host factors facilitating SARS‐CoV‐2 virus infection and replication in the lungs

S Boutin, D Hildebrand, S Boulant, M Kreuter… - Cellular and Molecular …, 2021 - Springer
SARS-CoV-2 is the virus causing the major pandemic facing the world today. Although,
SARS-CoV-2 primarily causes lung infection, a variety of symptoms have proven a systemic …

Cyclosporine A inhibits viral infection and release as well as cytokine production in lung cells by three SARS-CoV-2 variants

C Fenizia, S Galbiati, C Vanetti, R Vago… - Microbiology …, 2022 - Am Soc Microbiol
In December 2019, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
started spreading worldwide causing the coronavirus disease 2019 (COVID-19) pandemic …